Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Tom2013
    Member
    • Sep 2013
    • 20

    Change standard index sequence in sample sheet for Miseq

    We synthesized fusion primers (i.e p7(or p5)-index-Transposase- gene_specific_Primer) using the Nextera adapter and index sequences, and prepared a library for Miseq. When I prepared the sample sheet file for Miseq run, I noticed we used wrong sequence for only one index (N707): we used the reverse complementary sequence of N707 (the other index sequences are good).

    Now, I may have two options to fix this:
    1) use the default index sequences generated by the IEM software in the sample sheet; run Miseq as usual; most samples will be demultiplexed by the Miseq software except a few; then demultiplex the un-demultiplexed sequences for those samples that have used the N707 index.
    I still need to figure out how to demultiplex the sequences.

    2) After the sample sheet is generated, change the default N707 index sequence to the sequence that was actually synthesized, and then save the sample sheet for Miseq run. Will this work for Miseq software and sequencing?

    I prefer option 2), but not sure whether the Miseq run will be successful. Any ideas will be much appreciated.
  • microgirl123
    Senior Member
    • Jun 2012
    • 199

    #2
    Are you uploading to BaseSpace? If so, you just need to let the analysis finish up and then go in and fix your sample sheet and requeue the analysis under the "more" tab of the summary page. If you're not uploading to BaseSpace it's still possible to fix your sample sheet and re-analyze the data, just a bit more complicated.

    Comment

    • Tom2013
      Member
      • Sep 2013
      • 20

      #3
      Originally posted by microgirl123 View Post
      Are you uploading to BaseSpace? If so, you just need to let the analysis finish up and then go in and fix your sample sheet and requeue the analysis under the "more" tab of the summary page. If you're not uploading to BaseSpace it's still possible to fix your sample sheet and re-analyze the data, just a bit more complicated.
      No, I am not uploading to BaseSpace. I know re-analyzing data after Miseq run is complicated, as read1 and read2 do not contain barcode sequences.

      I wonder whether correcting that index sequence in sample sheet before Miseq run would work. Does change of default index sequence lead to Miseq run or demultiplexing fail?

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        Does change of default index sequence lead to Miseq run or demultiplexing fail?
        Demultiplexing may fail, if your indexes are non-standard and you provide standard indexes (but the run will not fail so don't worry). Edit the samplesheet and put the actual indexes you used. You should be able to demultiplex the data either locally on MiSeq or using standalone bcl2fastq. If you use the correct samplesheet when you start the run then everything should be fine.

        Comment

        • ajthomas
          Senior Member
          • Mar 2010
          • 167

          #5
          Originally posted by GenoMax View Post
          Demultiplexing may fail, if your indexes are non-standard and you provide standard indexes (but the run will not fail so don't worry). Edit the samplesheet and put the actual indexes you used. You should be able to demultiplex the data either locally on MiSeq or using standalone bcl2fastq. If you use the correct samplesheet when you start the run then everything should be fine.
          This is probably a bit late for you, but I'll chime in here with my own experience for those who come after. I needed more indexes than were available in any Illumina product. However, rather than make up my own index sequences, I collected all of Illumina's 8 bp indexes, put them together into one list, eliminated any that were duplicates or too similar to others, and renamed them into one sequence. When I use those, I just make the sample sheet in Excel and import it into Local Run Manager to create a run. The system has no problem with nonstandard indexes, or with standard index sequences with a different name.

          Comment

          • Tom2013
            Member
            • Sep 2013
            • 20

            #6
            Thanks for your reply. Option 2 worked well.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            32 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            43 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            29 views
            0 reactions
            Last Post SEQadmin2  
            Working...